Company	StageDateRound Size	Total Raised
Suki	Series DOct 2024$70M	$170M
Co-investors: Bill Geary (Flare Capital Partners), Wes Nichols (March Capital), Nat Turner (Operator Partners), Bradley Horowitz, Marc Benioff, Pankaj Patel
Element Biosciences	Series DJul 2024$280M Series CJun 2021$280M	$550M
Co-investors: Jim Tananbaum (Foresite Capital)
SmithRx	Series CJan 2024$60M Series BMar 2022$27M	$100M
Co-investors: Darian Shirazi (Gradient Ventures), Max Altman (Saga), Henry McNamara (Great Oaks Venture Capital), Bob Kocher (Venrock), Fabian Hansen (Presight Capital), Louis Beryl, Zachary Hargreaves, Konstantin von Unger
Mythic Therapeutics	Series BDec 2021$100M	$100M
Co-investors: Josh Kopelman (First Round Capital)
Stride Health	Series COct 2021$47M Series BAug 2017$24M Series AMay 2015$13M	$86M
Co-investors: Carl Byers (F-Prime Capital Partners), Bob Kocher (Venrock), Constance Freedman (Moderne Ventures), Kevin Nazemi, Jonathan Bush
The Public Health Company	SeedApr 2021$8M	$8M
Federation Bio	Series AOct 2020$50M	$50M
Co-investors: Racquel Bracken (Venrock)
Lyra Health	Series CMar 2020$75M Series UnknownMay 2018$65M Series AOct 2015$35M SeedJun 2015$3M	$520M
Co-investors: Somesh Dash (IVP), James Slavet (Greylock), Bob Kocher (Venrock), Stewart Gollmer (Tenaya Capital), Marc Stad (Dragoneer Investment Group), Howard Schultz, Paul George

Bryan Roberts